http://syn2.thecanadianpress.com:8080/mrss/feed/fcf7391a2f354311807f0501c16bde6a MSN - AP World Copyright © 2010-2018 The Canadian Press. All rights reserved. http://www.rssboard.org/rss-specification Mon, 24 Jan 2022 22:09:30 +0000 http://syn2.thecanadianpress.com:8080/mrss/feed/fcf7391a2f354311807f0501c16bde6a/3cb3d609294643b69e4f2b00e694d49b The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as government advisers endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds. The FDA panel voted that the vaccine's benefits outweigh risks. (Oct. 26) 3cb3d609294643b69e4f2b00e694d49b Tue, 26 Oct 2021 23:07:36 +0000 SHOTLIST:RESTRICTION SUMMARY: PART MUST CREDIT PFIZER, INC.PFIZER, INC. - MUST CREDIT PFIZER, INC.Location unknown - October 20211. Various of production, labeling and packaging of Pfizer's lower-dose vaccine for kids ++MUTE, PART SLOWED AT SOURCE++U.S. FOOD AND DRUG ADMINISTRATIONLocation unknown - 26 October 20212. SOUNDBITE (English) Dr. James Hildreth, temporary committee member:"If the trends continue the way they are going, the emergency for children is not what we might think it would be, and that's just my main concern.++WHITE FLASH++ 3. SOUNDBITE (English) Dr. Paul Offit, committee member:"It's always nerve wracking I think, when you're asked to make a decision for millions of children based on studies of only a few thousand children."++WHITE FLASH++4. SOUNDBITE (English) Dr. Paul Offit, committee member:"You never know everything. The question is whether you know enough, and I think we certainly know that there are many children between 5 and 11 years of age who are susceptible to this disease, who could very well be sickened or hospitalized or die from it."++WHITE FLASH++5. SOUNDBITE (English) Jeannette Lee, temporary committee member:"At one point we thought if we vaccinated enough people that the, the virus would go away. It's not going away, and I think we're going to have to find a way to live with it. And I think the vaccines kind of give us a way to do that."++WHITE FLASH++6. SOUNDBITE (English) Dr. Arnold Monto, committee chair, reading voting question: "Based on the totality of scientific evidence available, do the benefits of the Pfizer-BioNTech COVID-19 vaccine when administered as a two-dose series, 10 micrograms each dose, three weeks apart, outweigh its risks for use in children 5 to 11 years of age?"PFIZER, INC. - MUST CREDIT PFIZER, INC.Location unknown - October 20217. Various of production, labeling and packaging of Pfizer's lower-dose vaccine for kids ++MUTE, PART SLOWED AND BLURRED AT SOURCE++U.S. FOOD AND DRUG ADMINISTRATIONLocation unknown - 26 October 20218. SOUNDBITE (English) Kathleen Hayes, federal designated officer: "Out of 18 voting members, 17 voted yes, and we had one abstain."++ENDS ON SOUNDBITE++STORYLINE:The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as government advisers on Tuesday endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds.A Food and Drug Administration advisory panel voted unanimously, with one abstention, that the vaccine's benefits in preventing COVID-19 in that age group outweigh any potential risks. That includes questions about a heart-related side effect that's been very rare in teens and young adults despite their use of a much higher vaccine dose. While children are far less likely than older people to get severe COVID-19, ultimately many panelists decided it's important to give parents the choice to protect their youngsters — especially those at high risk of illness or who live in places where other precautions, like masks in schools, aren't being used.The FDA isn't bound by the panel's recommendation and is expected to make its own decision within days. If the FDA concurs, there's still another step: Next week, the CDC will have to decide whether to recommend the shots and which youngsters should get them.Full-strength shots made by Pfizer and its partner BioNTech already are recommended for everyone 12 and older but pediatricians and many parents are clamoring for protection for younger children. The extra-contagious delta variant has caused an alarming rise in pediatric infections, and families are frustrated with school quarantines and having to say no to sleepovers and other rites of childhood to keep the virus at bay.In the 5- to 11-year-old age group, there have been over 8,300 hospitalizations reported, about a third requiring intensive care, and nearly 100 deaths.States are getting ready to roll out the shots — just a third of the amount given to teens and adults — that will come in special orange-capped vials to avoid dosage mix-ups. More than 25,000 pediatricians and other primary care providers have signed up so far to offer vaccination, which will also be available at pharmacies and other locations.But for all that anticipation, there also are people who strongly oppose vaccinating younger children, and both FDA and its advisers were inundated with an email campaign seeking to block the Pfizer shot. ___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content.===========================================================Clients are reminded: (i) to check the terms of their licence agreements for use of content outside news programming and that further advice and assistance can be obtained from the AP Archive on: Tel +44 (0) 20 7482 7482 Email: info@aparchive.com(ii) they should check with the applicable collecting society in their Territory regarding the clearance of any sound recording or performance included within the AP Television News service (iii) they have editorial responsibility for the use of all and any content included within the AP Television News service and for libel, privacy, compliance and third party rights applicable to their Territory. The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as government advisers endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds. The FDA panel voted that the vaccine's benefits outweigh risks. (Oct. 26) FDA panel backs Pfizer's COVID-19 vaccine for kids